Dr. Chase on Challenges Facing Gynecologic Cancers

Dana M. Chase, MD, FACOG
Published: Tuesday, Apr 18, 2017



Dana M. Chase, MD, FACOG, an associate professor at Creighton University, University of Arizona College of Medicine, and gynecologic oncologist with Arizona Oncology, discusses challenges facing gynecologic cancers.

Endometrial cancer is most often cured with surgery, leaving only a small patient population that has recurrent disease. Finding funding for large randomized studies with that small patient group is more difficult, explains Chase.

Similarly, cervical and vulvar cancer are not as common, creating a challenge for getting drugs approved in those patients.



Dana M. Chase, MD, FACOG, an associate professor at Creighton University, University of Arizona College of Medicine, and gynecologic oncologist with Arizona Oncology, discusses challenges facing gynecologic cancers.

Endometrial cancer is most often cured with surgery, leaving only a small patient population that has recurrent disease. Finding funding for large randomized studies with that small patient group is more difficult, explains Chase.

Similarly, cervical and vulvar cancer are not as common, creating a challenge for getting drugs approved in those patients.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Redefining Ovarian Cancer Treatment Paradigms by Maximizing Therapeutic Outcomes with PARP InhibitorsSep 29, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x